Ameriprise’s iShares iBonds Dec 2019 Term Corporate ETF IBDK Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2019
Q4
Sell
-554,047
Closed -$13.8M 3841
2019
Q3
$13.8M Sell
554,047
-63,142
-10% -$1.57M 0.01% 1439
2019
Q2
$15.3M Buy
617,189
+19,268
+3% +$479K 0.01% 1370
2019
Q1
$14.8M Buy
597,921
+269,336
+82% +$6.69M 0.01% 1355
2018
Q4
$8.15M Buy
328,585
+17,128
+5% +$424K ﹤0.01% 1764
2018
Q3
$27.6M Sell
311,457
-35,720
-10% -$885K 0.01% 1077
2018
Q2
$8.6M Buy
347,177
+89,629
+35% +$2.22M ﹤0.01% 1858
2018
Q1
$7.27M Buy
257,548
+154,977
+151% +$3.84M ﹤0.01% 1900
2017
Q4
$2.56M Buy
102,571
+15,467
+18% +$385K ﹤0.01% 2539
2017
Q3
$2.17M Buy
87,104
+1,038
+1% +$26K ﹤0.01% 2572
2017
Q2
$2.15M Buy
86,066
+11,495
+15% +$287K ﹤0.01% 2566
2017
Q1
$1.86M Buy
74,571
+33,331
+81% +$832K ﹤0.01% 2607
2016
Q4
$1.03M Buy
41,240
+18,002
+77% +$450K ﹤0.01% 2963
2016
Q3
$584K Buy
23,238
+7,620
+49% +$192K ﹤0.01% 3121
2016
Q2
$395K Buy
+15,618
New +$392K ﹤0.01% 3265

Other funds holding IBDK

Ameriprise's IBDK Position: Q4 2019 in Review

Ameriprise sold out of iShares iBonds Dec 2019 Term Corporate ETF (IBDK) in Q4 2019, closing a stake of 554,047 shares — an estimated $13.8M sold.

Ameriprise first reported a position in IBDK in Q2 2016 and held it in 14 quarters. The position peaked at $27.6M in Q3 2018. 1 fund tracked by Wall St. Rank holds IBDK as of Q4 2019.

  • Ameriprise reported no remaining iShares iBonds Dec 2019 Term Corporate ETF position as of Q4 2019 after selling out during the quarter.
  • Ameriprise sold 554,047 iShares iBonds Dec 2019 Term Corporate ETF shares in Q4 2019, an estimated $13.8M.
  • Ameriprise first reported a position in iShares iBonds Dec 2019 Term Corporate ETF in Q2 2016 and held it in 14 quarters.
  • Ameriprise's iShares iBonds Dec 2019 Term Corporate ETF position peaked at $27.6M in Q3 2018.
  • 1 fund tracked by Wall St. Rank held iShares iBonds Dec 2019 Term Corporate ETF as of Q4 2019.

Based on Ameriprise's 13F filing for Q4 2019, filed 14 Feb 2020.